Corroborating our findings, a recent study have shown in prostate cancer that the action of estrogen on oxidative stress and the expression of antioxidant enzymes is dual and dependent on the ERα/ERβ ratio[37]. This evidence concerns the gene ESR2 and prostate carcinoma.